SG10202005580RA - Methods for the preparation of charged crosslinkers - Google Patents
Methods for the preparation of charged crosslinkersInfo
- Publication number
- SG10202005580RA SG10202005580RA SG10202005580RA SG10202005580RA SG10202005580RA SG 10202005580R A SG10202005580R A SG 10202005580RA SG 10202005580R A SG10202005580R A SG 10202005580RA SG 10202005580R A SG10202005580R A SG 10202005580RA SG 10202005580R A SG10202005580R A SG 10202005580RA
- Authority
- SG
- Singapore
- Prior art keywords
- preparation
- methods
- charged crosslinkers
- crosslinkers
- charged
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
- C07D213/71—Sulfur atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/32—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C305/00—Esters of sulfuric acids
- C07C305/02—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton
- C07C305/04—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton being acyclic and saturated
- C07C305/06—Hydrogenosulfates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
- C07D207/444—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5
- C07D207/448—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. maleimide
- C07D207/452—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. maleimide with hydrocarbon radicals, substituted by hetero atoms, directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/36—Sulfur-, selenium-, or tellurium-containing compounds
- C08K5/37—Thiols
- C08K5/372—Sulfides, e.g. R-(S)x-R'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Pyridine Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Manufacture Of Macromolecular Shaped Articles (AREA)
- Polyamides (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42135710P | 2010-12-09 | 2010-12-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10202005580RA true SG10202005580RA (en) | 2020-07-29 |
Family
ID=46207513
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10202005580RA SG10202005580RA (en) | 2010-12-09 | 2011-12-08 | Methods for the preparation of charged crosslinkers |
| SG2013035555A SG190214A1 (en) | 2010-12-09 | 2011-12-08 | Methods for the preparation of charged crosslinkers |
| SG10201509886YA SG10201509886YA (en) | 2010-12-09 | 2011-12-08 | Methods for the preparation of charged crosslinkers |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2013035555A SG190214A1 (en) | 2010-12-09 | 2011-12-08 | Methods for the preparation of charged crosslinkers |
| SG10201509886YA SG10201509886YA (en) | 2010-12-09 | 2011-12-08 | Methods for the preparation of charged crosslinkers |
Country Status (19)
| Country | Link |
|---|---|
| US (5) | US8598362B2 (he) |
| EP (2) | EP2648510B1 (he) |
| KR (1) | KR101959578B1 (he) |
| CN (2) | CN107011253B (he) |
| CY (1) | CY1121055T1 (he) |
| DK (1) | DK3153504T3 (he) |
| ES (2) | ES2702926T3 (he) |
| HR (1) | HRP20182026T1 (he) |
| HU (1) | HUE041699T2 (he) |
| IL (3) | IL226795A (he) |
| LT (1) | LT3153504T (he) |
| PL (1) | PL3153504T3 (he) |
| PT (1) | PT3153504T (he) |
| RS (1) | RS58033B1 (he) |
| SG (3) | SG10202005580RA (he) |
| SI (1) | SI3153504T1 (he) |
| SM (1) | SMT201800666T1 (he) |
| TR (1) | TR201819440T4 (he) |
| WO (1) | WO2012078868A1 (he) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8598362B2 (en) * | 2010-12-09 | 2013-12-03 | Immunogen, Inc. | Methods for the preparation of charged crosslinkers |
| JP6026305B2 (ja) | 2013-02-04 | 2016-11-16 | 古河電気工業株式会社 | 標識抗体の製造方法 |
| WO2014210267A1 (en) | 2013-06-28 | 2014-12-31 | Immunogen, Inc. | Purification of intermediates used in the preparation of heterobifunctional linkers |
| US10208125B2 (en) | 2013-07-15 | 2019-02-19 | University of Pittsburgh—of the Commonwealth System of Higher Education | Anti-mucin 1 binding agents and uses thereof |
| US10464955B2 (en) | 2014-02-28 | 2019-11-05 | Hangzhou Dac Biotech Co., Ltd. | Charged linkers and their uses for conjugation |
| CN104892748B (zh) * | 2014-03-04 | 2018-12-21 | 深圳翰宇药业股份有限公司 | 人类松弛素-2衍生物以及由其制备人类松弛素-2的方法 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1926422A (en) | 1930-12-29 | 1933-09-12 | Fred C Armbruster | Pipe joint |
| DE800410C (de) * | 1948-10-02 | 1950-11-06 | Basf Ag | Verfahren zur Herstellung von Lactonsulfonsaeuren |
| US2822387A (en) * | 1955-12-07 | 1958-02-04 | Universal Oil Prod Co | Method of producing sulfonated alkanes |
| US3418290A (en) * | 1965-10-18 | 1968-12-24 | Du Pont | Sulfonated caprolactones and polymerization with 2,2-dialkyl-3-propiolactones |
| US4244885A (en) * | 1977-12-08 | 1981-01-13 | Yeda Research And Development Co. Ltd. | α-Substituted-3-(halomethyl)-4-hydroxybenzeneacetic acids |
| US4563304A (en) | 1981-02-27 | 1986-01-07 | Pharmacia Fine Chemicals Ab | Pyridine compounds modifying proteins, polypeptides or polysaccharides |
| US5208020A (en) | 1989-10-25 | 1993-05-04 | Immunogen Inc. | Cytotoxic agents comprising maytansinoids and their therapeutic use |
| DE69231123T2 (de) | 1992-03-25 | 2001-02-15 | Immunogen Inc | Konjugaten von Zell-bindender Mittel und Derivaten von CC-1065 |
| CA2130723C (en) * | 1993-09-03 | 2006-01-31 | Wilhelm Quittmann | Process for preparing y-mercaptocarboxylic acid derivatives |
| DE19609338A1 (de) | 1996-03-11 | 1997-09-18 | Hoechst Ag | Benzothioxanthen-Farbstoffe, ihre Herstellung und ihre Verwendung |
| CA2388063C (en) | 1999-11-24 | 2010-06-08 | Immunogen, Inc. | Cytotoxic agents comprising taxanes and their therapeutic use |
| US6716821B2 (en) | 2001-12-21 | 2004-04-06 | Immunogen Inc. | Cytotoxic agents bearing a reactive polyethylene glycol moiety, cytotoxic conjugates comprising polyethylene glycol linking groups, and methods of making and using the same |
| US6756397B2 (en) | 2002-04-05 | 2004-06-29 | Immunogen, Inc. | Prodrugs of CC-1065 analogs |
| AU2003225305A1 (en) | 2002-05-08 | 2003-11-11 | Bristol-Myers Squibb Company | Pyridine-based thyroid receptor ligands |
| EP1542723B1 (en) | 2002-08-16 | 2011-02-23 | ImmunoGen, Inc. | Cross-linkers with high reactivity and solubility and their use in the preparation of conjugates for targeted delivery of small molecule drugs |
| US7276497B2 (en) | 2003-05-20 | 2007-10-02 | Immunogen Inc. | Cytotoxic agents comprising new maytansinoids |
| EP1688415A1 (en) | 2004-12-07 | 2006-08-09 | Aventis Pharma S.A. | Cytotoxic agents comprising new C-2 modified taxanes |
| NZ588851A (en) | 2008-04-30 | 2013-05-31 | Immunogen Inc | Potent conjugates and hydrophilic linkers |
| DK2281006T3 (da) * | 2008-04-30 | 2017-11-06 | Immunogen Inc | Tværbindingsmidler og anvendelser deraf |
| EP3100745B1 (en) | 2009-02-05 | 2018-04-18 | Immunogen, Inc. | Novel benzodiazepine derivatives |
| US8598362B2 (en) * | 2010-12-09 | 2013-12-03 | Immunogen, Inc. | Methods for the preparation of charged crosslinkers |
-
2011
- 2011-12-08 US US13/315,005 patent/US8598362B2/en active Active
- 2011-12-08 ES ES16186412T patent/ES2702926T3/es active Active
- 2011-12-08 LT LTEP16186412.9T patent/LT3153504T/lt unknown
- 2011-12-08 CN CN201610836137.XA patent/CN107011253B/zh active Active
- 2011-12-08 WO PCT/US2011/063944 patent/WO2012078868A1/en active Application Filing
- 2011-12-08 SI SI201131636T patent/SI3153504T1/sl unknown
- 2011-12-08 SG SG10202005580RA patent/SG10202005580RA/en unknown
- 2011-12-08 SM SM20180666T patent/SMT201800666T1/it unknown
- 2011-12-08 KR KR1020137015769A patent/KR101959578B1/ko active IP Right Grant
- 2011-12-08 PL PL16186412T patent/PL3153504T3/pl unknown
- 2011-12-08 SG SG2013035555A patent/SG190214A1/en unknown
- 2011-12-08 RS RS20181471A patent/RS58033B1/sr unknown
- 2011-12-08 DK DK16186412.9T patent/DK3153504T3/en active
- 2011-12-08 EP EP11846704.2A patent/EP2648510B1/en active Active
- 2011-12-08 CN CN201180059248.XA patent/CN103260406B/zh active Active
- 2011-12-08 ES ES11846704.2T patent/ES2602118T3/es active Active
- 2011-12-08 PT PT16186412T patent/PT3153504T/pt unknown
- 2011-12-08 HU HUE16186412A patent/HUE041699T2/hu unknown
- 2011-12-08 TR TR2018/19440T patent/TR201819440T4/tr unknown
- 2011-12-08 EP EP16186412.9A patent/EP3153504B1/en active Active
- 2011-12-08 SG SG10201509886YA patent/SG10201509886YA/en unknown
-
2013
- 2013-06-06 IL IL226795A patent/IL226795A/he active IP Right Grant
- 2013-10-03 US US14/045,151 patent/US8921566B2/en active Active
-
2014
- 2014-11-12 US US14/539,361 patent/US9242936B2/en active Active
-
2015
- 2015-07-28 IL IL240200A patent/IL240200A/he active IP Right Grant
- 2015-07-28 IL IL240201A patent/IL240201A0/he unknown
- 2015-12-15 US US14/969,720 patent/US9663492B2/en active Active
-
2017
- 2017-04-25 US US15/496,775 patent/US10112925B2/en active Active
-
2018
- 2018-12-03 HR HRP20182026TT patent/HRP20182026T1/hr unknown
- 2018-12-10 CY CY181101315T patent/CY1121055T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1253006A1 (zh) | 製備截短側耳素的工藝 | |
| PT2539136T (pt) | Poste de barreira e método de fabrico do mesmo | |
| ZA201305972B (en) | Method for the preparation of biphephos | |
| ZA201103820B (en) | Process for the preparation of tenofovir | |
| HRP20182026T1 (hr) | Postupci za pripremu nabijenih sredstava za umrežavanje | |
| SG11201400939YA (en) | Process for the preparation of methoxymelonal | |
| IL226436A0 (he) | שיטות עבור הכנת בנדאמוסטין | |
| EP2596007A4 (en) | PROCESS FOR THE PREPARATION OF 17-DEOXY-CORTICOSTEROIDS | |
| ZA201300546B (en) | Process for the preparation of 3-haloalkylpyrazoles | |
| PT2603319E (pt) | Processo para a preparação de uretanos | |
| PT2593423E (pt) | Processo para a preparação de agentes de contraste | |
| PT2390246T (pt) | Processo para a preparação de aminaftona | |
| PL2702045T3 (pl) | Nowy sposób sporządzania Etrawiryny | |
| HUP1000018A2 (en) | Process for the preparation of distrontium ranelate | |
| PL2598504T3 (pl) | Sposób otrzymywania dimiracetamu | |
| ZA201209495B (en) | Novel methods for the preparation of p2x7r antagonists | |
| TWM389392U (en) | Structural improvement of charger | |
| IL224304A (he) | תהליך להכנת דיכלורופולבן | |
| GB201019078D0 (en) | Process for the preparation of rosuvastatin | |
| GB201012186D0 (en) | Methods for the preparation of cellular therapies | |
| IL211422A0 (en) | Methods of requcing the power of stsong destzuctive eaztnquakes | |
| PL394420A1 (pl) | Sposób wytwarzania dilauroilofluoresceiny | |
| PL394378A1 (pl) | Sposób otrzymywania E-2-amino-4-nitrostilbenów | |
| PL391682A1 (pl) | Sposób otrzymywania ε-kaprolaktonu |